intranasal dexmedetomidine is of benefit as paediatric ... · objective: to provide new knowledge...

25
Sykepleien Forskning 2018 13(71340)(e-71340) DOI: https://doi.org/10.4220/Sykepleienf.2018.71340 PEER-REVIEWED RESEARCH Intranasal dexmedetomidine is of benefit as paediatric premedication – from the perspective of anaestetic nurses Dexmedetomidine Children Premedication Anaesthetic nursing Anaesthetics Qualitative study Abstract Avdelingssykepleier Anestesiavdelingen, Stavanger universitetssjukehus Avdelingssykepleier Anestesiavdelingen, Stavanger universitetssjukehus Professor emeritus Det helsevitenskapelige fakultet, Universitetet i Stavanger Authors Linn Kristin R. Berland Inger Brit T. Bakkalia Elin Dysvik

Upload: others

Post on 18-Oct-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

Sykepleien Forskning 2018 13(71340)(e-71340)DOI: https://doi.org/10.4220/Sykepleienf.2018.71340

PEER-REVIEWED RESEARCH

Intranasaldexmedetomidine is ofbenefit as paediatricpremedication – from theperspective of anaesteticnurses

Dexmedetomidine Children Premedication Anaesthetic nursing Anaesthetics

Qualitative study

Abstract

AvdelingssykepleierAnestesiavdelingen, Stavanger universitetssjukehus

AvdelingssykepleierAnestesiavdelingen, Stavanger universitetssjukehus

Professor emeritusDet helsevitenskapelige fakultet, Universitetet i Stavanger

Authors

Linn Kristin R. Berland

Inger Brit T. Bakkalia

Elin Dysvik

Page 2: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

Background: Nasal administration of the drug dexmedetomidine is increasingly used forchildren who need sedation and premedication before anaesthesia and surgery.Midazolam, which currently is most widely used, is associated with a number of adverseeffects. There is thus a need for alternative paediatric premedication to improve treatmentprovision.

Objective: To provide new knowledge on the properties of dexmedetomidine and howthis drug is suited as premedication for children who will be given general anaesthesia,seen from the perspective of the anaesthetic nurse.

Method: We conducted semi-structured interviews. The sample consisted of sixanaesthetic nurses from two day surgery units in two different hospitals. We analysed thedata with the aid of qualitative content analysis.

Results: We identified two main topics: 1) Dexmedetomidine as premedication hasfavourable properties throughout the anaesthetic process. 2) Necessary precautions needto be taken throughout the anaesthetic process to ensure that no complications arise whendexmedetomidine is used as premedication. In general, the findings show thatdexmedetomidine provides satisfactory sedation in the form of sleep preoperatively. It isfound that the children are easy to wake up from their sedation. This means that thechildren need minimum exposure to stimulation before and during the induction ofanaesthesia. However, the long onset time of dexmedetomidine necessitatesinterdisciplinary collaboration to achieve an efficient patient flow. The anaesthetic nursesdid not describe any serious adverse effects of the drug.

Conclusion: New knowledge from the perspective of the anaesthetic nurses shows thatdexmedetomidine is perceived as a suitable alternative to premedication for children. Thedisadvantages were described as minor when compared to the advantages provided bydexmedetomidine used as premedication, with favourable effects prior to, during and aftersurgery. The anaesthetic nurses faced some challenges in the use of dexmedetomidine atthe start of the introduction process, but experience with the drug’s properties showed thatto use it successfully and safely, necessary precautions must be taken throughout theanaesthetic process. The findings show that new procedures should be introduced by wayof internal pilot projects.

The drug dexmedetomidine is increasingly used forsedation and premedication in children (1).Dexmedetomidine enables a saving on analgesic andanaesthetic agents, has a minimal effect on respirationand can be administered by different routes (1–3). Theintranasal route is minimally traumatic, anddexmedetomidine is taste-free, odour-free and painlesswhen used on the nasal mucous membrane, and thedrug is therefore well tolerated by children (4, 5).

Page 3: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The benzodiazepine derivate midazolam provides goodsedation and thus reduces anxiety, and is the mostfrequently used drug for paediatric premedication (2,6, 7). The adverse effects of midazolam, such as foultaste, stinging pain when used intranasally, respiratorydepression and in some cases increased agitation,nevertheless makes it a suboptimal choice (1, 3, 8).There is a need for an alternative paediatricpremedication to improve treatment at the pre-, per-and post-operative stage (9).

Research has estimated that 40–70 per cent of allchildren of pre-school age experience anxiety inconnection with a surgical procedure (1, 3, 8). Anxietymay complicate the induction of anaesthesia, which isstressful for the child, the parents and the anaestheticsteam. The parents’ experience at this stage has asignificant effect on their satisfaction with thetreatment programme (7, 9).

Reducing the children’s anxiety preoperatively helpsprevent complications. A high level of anxiety anddifficult induction of anaesthetics are a risk factor forpost-operative complications such as agitation, morepain and long-term, negative behavioural change suchas bedwetting, reduced appetite and temper tantrums.Such complications may delay the departure fromhospital and rehabilitation (7, 10, 11).

The anaesthetic nurse and the anaesthesiologistconstitute an anaesthetics team that collaboratesclosely in a complex and dynamic environment, withoverlapping job tasks. The doctor holds medicalresponsibility in the team (12).

Surgery invokes anxiety

«Reducing the children’s anxiety preoperativelyhelps prevent complications.»

Teamwork

Page 4: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The anaesthetic nurse has an independent function andan expanded nursing competence that requires specifictechnical and non-technical skills. This competence isrequired to be able to observe, identify and assessdifferent situations and take action to meet thecomplex needs of the patient who is about to undergosurgery and anaesthesia. The objective is to ensurepatient safety and appropriate professional practice(12, 13).

Literature searches revealed a number of quantitativestudies describing the use of dexmedetomidine aspaediatric premedication. Various academic articlesindicate that dexmedetomidine is well suited aspremedication and sedation for children down to theage of one year. Research also shows that the use ofdexmedetomidine has positive effects at the post-operative stage, including calmer and less painfulawakenings (1, 3, 8).

However, we found no studies that had taken aqualitative approach to this question. Demands forappropriate professional procedures must be groundedin evidence-based practices, meaning thatprofessionals make use of a variety of knowledgesources in the practice of their profession (14–16). Forprocedures to be changed, they need to be perceived asmore suitable than those that are established.

Based on the above considerations, the objective of ourstudy was to explore the experiences of anaestheticnurses, in order to contribute new knowledge about theproperties and suitability of dexmedetomidine aspaediatric premedication. These aspects form thebackdrop to the following research question:

What experiences do anaesthetic nurses have withthe use of intranasal dexmedetomidine aspremedication at the pre-, per- and post-operative

Objective of the study

Page 5: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

stage in children who will be placed under generalanaesthesia?

We used a qualitative, exploratory design that involvedsemi-structured interviews with anaesthetic nurses.This method is appropriate to capture the participants’personal experiences by taking an open view (17, 18).The study is based on a phenomenological-hermeneutic tradition, in which reality is described asdiverse and subjective, and findings are created ininteractive processes. On the other hand, findings mustbe interpreted in light of relevant studies and theresearchers’ preconceptions to obtain a morecomprehensive understanding (17).

The goal of qualitative research is to includeparticipants that can provide the richest possibledescriptions in order to elucidate the research question(17). Contact persons in the hospitals recruited theparticipants based on the following inclusion criteria:

must be an anaesthetic nurse with at least one yearof experience

works with children on a routine basis

possesses clinical experience with intranasaladministration of dexmedetomidine

includes both genders

Based on the inclusion criteria, six anaesthetic nurseswere asked to participate in the study, all of whomassented. They made up the strategic sample on whichthe data collection was based. Average clinicalexperience as an anaesthetic nurse, from work withchildren and the use of dexmedetomidine aspremedication amounted to 14.8 years (3–21 years),16.3 years (3–21 years) and 2.2 years (0.5–4 years)respectively.

MethodDesign

Sample

Page 6: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The anaesthetic nurses were recruited from daysurgery units in two Norwegian hospitals. The unitshad been established three and seven years agorespectively, and consisted of five to six operatingtheatres with appurtenant pre- and post-operative units.In general, the personnel was permanently linked tothe departments, and surgical interventions includedotorhinolaryngology, gynaecology, thoracic andendocrine surgery, orthopaedics and general surgery.Both departments operated on more than 800 childrenannually, mainly related to ear, nose and throatconditions.

The project is approved by the Norwegian Centre forResearch Data (NSD) (project no. 50198) and by theheads of research in the hospitals. Prior to theinterviews all participants received written informationabout the project accompanied by an invitation toparticipate in the study. They were informed abouttheir right to withdraw at any time with norepercussions. They accepted to participate by comingfor an interview.

All information about the participants was treated asconfidential, in line with the NSD guidelines andprinciples of research ethics. The participants werecoded with random numbers ranging from one to six,and all data were anonymised.

We collected the data in the autumn of 2016 with theaid of personal in-depth interviews conducted in theparticipants’ workplace. A semi-structured interviewguide (Appendix 1) was used to focus the interviewand encourage the participants to speak as freely aspossible (17). The interviews lasted from 30 to 60minutes. We used a digital audio device to record theinterviews, which were subsequently transcribed.

Ethical considerations

Data collection and analysis

Page 7: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

We analysed the data in light of Graneheim andLundman’s (19) qualitative content analysis through asix-step abstraction process (Table 1). The text wasdivided into four natural domains in accordance withthe three stages of the anaesthesia process plus theinduction stage, and these constitute the units ofmeaning in the text.

Through this abstraction process two main topicsemerged: 1) dexmedetomidine as premedication hasfavourable properties throughout the anaestheticprocess, and 2) Necessary precautions need to be takenthroughout the anaesthetic process to ensure that nocomplications arise when dexmedetomidine is used aspremedication (Table 2).

Page 8: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The anaesthetic nurses in both units described howdexmedetomidine was introduced after an intra-departmental pilot project. Participant 4 emphasisedthe importance of preparation: ‘It was well accepted byeverybody, both in terms of the training and the‘internal research’, where we compared children whohad received dexmedetomidine, midazolam andnothing.’

ResultsPre-operative experience

Page 9: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

Some challenges were encountered initially, asdescribed by Participant 2: ‘Of course there was abreaking-in period concerning the dosage and timing,but it was well received. The favourable effectsmanifested themselves early.’

The anaesthetic nurses believed that the successfulintroduction of the new drug was largely due to thefact that the process was clinically endorsed by theunit’s anaesthesiologist. Participant 3 noted: ‘It’sessential to have an authority in the professional groupwhen starting something new.’

The anaesthetic nurses had observed thatdexmedetomidine induces sleep. Participant 2 gave anaccount of the following experience: ‘The childrenreceive it, and when it takes effect they fall asleep …You can insert a cannula, take them to the operatingtheatre and initiate anaesthesia without them noticing.But little time must elapse once they have fallenasleep.’

All participants found that the children could be wokenup and had to be exposed to as little stimulation aspossible. Participant 3 described it thus: ‘It’s an art toensure that they do not wake up … Having permanentstaff who know how this works is an advantage … Itworks really well now.’

Experience indicated that the onset time fordexmedetomidine varied from 20 minutes up to onehour. This long onset time might delay patient flow inthe morning hours. Participant 6 said: ‘The first childin the morning is a challenge. You must take the timeneeded and wait for the effect. For this you need awell-functioning system … I nevertheless feel that Ihave a better daily situation with the children now.’

Positive effects for patient flow

Page 10: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

Participant 5 had the following experience: ‘Theoptimal time to administer dexmedetomidine is onehour before the surgical procedure.’

The anaesthetic nurses felt that interdisciplinarycollaboration was crucial to achieve an efficient patientflow. Participant 2 described it thus: ‘The intensive-care nurses in the post-operative ward administerdexmedetomidine to the children when they arrive inthe morning. They call us once the child has passed‘the hand test’. Then, they are in a deep enough sleepto have an injection.’

Participant 5 gave this description: ‘We have a verygood plan for solving this … Everybody is involved.Collaboration is easy here, compared to in a largedepartment.’

Despite the long onset time, the anaesthetic nursesfound that using dexmedetomidine had a positiveeffect on patient flow. Participant 3 had the followingexperience: ‘The gain lies in the shorter inductiontime.’

Negative experiences gathered by the anaestheticnurses were associated with some cases ofunsatisfactory effect. Participant 3 said that: ‘It wouldbe those who wake up and are agitated. It’s crucial tobring them into the operating theatre within the timewindow.’

No experiences of serious adverse effects weredescribed. Participant 4 had observed the following:‘Once they have received the dexmedetomidine, thechildren turn pale around the mouth. They have a briefdrop in oxygen saturation, although it never fallsbelow 95 per cent.’

Negative experiences

Page 11: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

It was clear that the anaesthetic nurses sawdexmedetomidine as a better alternative thanmidazolam as a paediatric premedication. This wasconfirmed by Participant 4: ‘The nurses in the post-operative ward do not want to revert to midazolam.’

The anaesthetic nurses perceived the inductions asgentle and safer than with awake and frightenedchildren. Participant 3 described it thus: ‘The inductionis perceived as very positive. A calm, sleeping childprovides for a much better overview compared topreviously, when this often involved quite a struggle.Safety is good … Compared to previously, it’s a newera.’

A general experience was that most children wentfrom ‘sleep to sleep’, but this was contingent onminimal stimulation. Participant 5 explained: ‘Theinduction goes very gently. Only a pulse oximeter tobegin with. We hold the mask lightly over the face soas not to wake them up. Once they are under fullanaesthesia we move them to the operating table.’

The participants felt that most parents were satisfied.Participant 1 said: ‘Fewer parents leave the operatingtheatre in tears, because they feel that we are incontrol. They see a child who sleeps his or her wayinto anaesthesia … I believe they see us as moreprofessional than before … We provide a system thatmakes me proud.’

Experiences during induction

Participant 3

«Safety is good … Compared to previously, it’s a newera.»

Perioperative experiences

Page 12: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

All participants noted that dexmedetomidine caninduce circulatory fluctuations, and bradycardia inparticular. Participant 2 described it thus: ‘There’sbeen talk about bradycardia, and we administerRobinul prophylactically during the induction, but Idon’t feel that this is a major problem.’

All participants noted the potentiating properties ofdexmedetomidine, meaning that this drug amplifies theeffect of other drugs, which in turn means that less ofthese can be used. Participant 6 nevertheless found: ‘Itreduces the use of opioids, but I can’t say that I noticeanything during the surgery. We use approximately thesame TIVA (total intravenous anaesthesia) settings forall patients. It works well.’

The participants described a close, interdisciplinarycollaboration in the day surgery units where thechildren stayed in the pre-, peri-, and post-operativestages. All participants shared the experience that therecoveries were characterised by less crying, agitationand pain. Participant 1 gave the following account:‘It’s just wonderful. It’s so different. The children aresleeping and are OK … The goal is for them to sleepthrough the distressing phase of recovery.’

In the experience of Participant 5, certain precautionsnevertheless needed to be taken. ‘Not too much timeshould elapse from the administration ofdexmedetomidine until the child goes into surgery andcomes to the recovery unit. And the children musthave the opportunity to wake up quietly.’

The anaesthetic nurses had observed that the childrenslept longer post-operatively after having been givendexmedetomidine as premedication. They did notbelieve, however, that this entailed any significantconsequences for patient turnover. Participant 4 said:‘The disadvantage is that there may be a backlog in thepost-operative ward, but it’s not a major problem.’

Post-operative experiences

Page 13: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The objective of this study was to investigate theexperiences of anaesthetic nurses at the pre-, peri‑, andpost-operative stage with the use of intranasaldexmedetomidine as premedication for children whowill be placed under general anaesthesia. In thediscussion we will mainly focus on the pre-operativestage, because this stage is considered critical and themost comprehensive findings are also related to thisstage.

The pre-operative stage is challenging andencompasses the time from when the patient isadmitted, premedication is administered andanaesthesia is induced (20). The anaesthetic nursefocuses on observing, identifying and assessing thechild’s needs and on implementing measures to ensurethat the treatment programme is individually adaptedto the greatest possible extent. The objective of thesemeasures includes ensuring patient safety andappropriate execution of tasks, thus to avoid adverseevents (12, 13).

The anaesthetic nurses included in this study hadobserved that dexmedetomidine induced good sleeppreoperatively when sufficient time was allotted to letthe drug take effect. When it worked as intended, thechildren slept through the insertion of a venouscannula and the induction of anaesthesia. Theinformants did not describe any adverse effects in theform of respiratory depression or circulatorydisturbances that required treatment.

Discussion

Pre-operative experiences and experiences duringinduction

Page 14: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The anaesthetic nurses reported positive experienceswhen dexmedetomidine ‘worked as intended’. Theynevertheless described a number of challengesassociated with dexmedetomidine used aspremedication. Issues included absent and variableeffects and onset times with identical dosages,especially at the breaking-in stage when the drug wasunfamiliar to them. The literature indicates that inorder to be effective, premedication should have arapid and reliable onset (1).

The participants’ experience of varying effects andonset times can be related to the fact that the drug isadministered via the intranasal route, which gives amore unreliable onset than intravenous administration,for example. Knowledge about pharmacokinetics andpharmacodynamic properties is therefore essentialwhen anaesthetic nurses administer drugs, includingwith a view to patient safety (21, 22). Provision ofindividually adapted dosages and prevention ofadverse events should be a goal (21).

All of the anaesthetic nurses described how thechildren could easily be woken up from sedation withdexmedetomidine. For example, they needed to findthe optimal time and the best procedure for inserting avenous cannula and starting the induction ofanaesthesia without the child waking up. According tothe participants, this timing was ‘an art’.

Easy to wake up

«All of the anaesthetic nurses described how thechildren could easily be woken up from sedation withdexmedetomidine.»

Page 15: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

According to Yuen (23), sleep induced bydexmedetomidine resembles regular sleep, and thelevel of sedation is dose-dependent. Lower plasmaconcentrations result in lighter sedation. Theexperience of our participants could also be related tothe fact that stimulation ought to happen at maximumplasma concentration of dexmedetomidine (22).

The anaesthetic nurses had found positive experienceswith doses of 2 µg/kg to the youngest children, agedone to four years. They reported that in the beginningthey faced some challenges in finding an appropriatedosage for children over the age of four. When theeffect was unsatisfactory, they repeated the initialdosage. Some of them also reported that for childrenweighing more than 12 kg, they adjusted the dosageupwards to 2.5 µg/kg. The time of onset was reportedas lasting from 20 minutes to one hour.

These findings are largely consistent with the findingsin the study conducted by Yuen and collaborators (24).The latter study indicates a time of onset varying from25–30 minutes after a dosage of 1 µg/kg. The findingsin our study corroborate those of Yuen andcollaborators (25), which describe how children fromfive to eight years had a significantly poorer effect of adose of 1 µg/kg when compared to children aged 1–4years. They conclude that a dosage of 2 µg/kg resultsin a satisfactory sedation of children (25).

Our findings show, however, that such premedicationfor the oldest children more often must be assessedindividually. A recent study by Tug and collaborators(26) indicates that dexmedetomidine in doses of 4µg/kg could be administered to sedate children fromone to 10 years for MRI scanning without detection ofrespiratory depression or circulatory disturbances thatrequired treatment.

Correct dosages for different children

Page 16: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The findings in our study corroborate previousresearch on the challenges involved in finding thecorrect dosage of intranasal dexmedetomidine (25, 26).These studies nevertheless describe dexmedetomidineas a safe drug, even when used at high dosage.

The anaesthetic nurses believed that the long onsettime of the drug might cause problems for patient flow,especially at the start of work in the morning. Theysaid that for the children to benefit fromdexmedetomidine as premedication, the drug needed totake effect before they started working with thechildren. The anaesthetic nurses describedinterdisciplinary collaboration in the department ascrucial to solving logistical challenges.

This practice illustrates Bjørk and Solhaug’s (27)description of how innovations are introduced. This isnot a solo task, it depends on collaboration among allmembers of the ward community to succeed. Someparticipants emphasised how collaboration acrossprofessional groups gave rise to shared ‘ownership’ ofthe project. This sentiment promoted a proactiveapproach and a positive commitment in the units, and afocus on the best interests of the child.

Many participants described how efficiency improvedwhen dexmedetomidine worked as intended andplanning succeeded. Our findings elucidate the highlevel of motivation among the staff to succeed with theuse of dexmedetomidine, despite the challengesinvolved. It became clear that the anaesthetic nurseshave felt the need for a suitable alternative drug forpremedication of children.

Collaboration is essential

Page 17: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The anaesthetic nurses described how the successfulintroduction of dexmedetomidine depended oncollaboration with the department’s anaesthesiologist.The anaesthesiologist’s knowledge about the drug andbelief in its suitability as a paediatric premedicationmeant that the introduction process enjoyed strongsupport.

Flynn and collaborators (12) emphasise the importanceof good teamwork between the anaesthesiologist andthe anaesthetic nurse as a factor that ensures provisionof appropriate health-promoting measures to patientsand improves patient safety. Good teamwork ischaracterised by mutual trust and respect for theexpertise of the other (12). The anaesthetic nurses inour study highlighted exactly this kind of collaborationwith the anaesthesiologist.

Bjørk and Solhaug (27) describe that in order tosucceed, it is extremely important for professionaldevelopment projects to be endorsed by the departmentmanagement or other people in authority. Findings inour study clearly show the complexity involved inintroducing new medical routines. Concerns forefficient and safe running of the unit must beprioritised, although the most important factor is theway in which the children and their parents perceivethe treatment programme. Developing such projectsrequires information flow and collaboration betweenthe professional groups in the institution (27).

The drug was not anxiety-inducing

Page 18: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The participants perceived the induction of anaesthesiawith the sleeping children as safer than with childrenwho are awake and resist. According to Scully (7),children’s anxiety with regard to the unknownincreases at this stage, and the induction of anaesthesiamay thus be a negative experience. The risk ofanaesthesia-related complications is generally higher atthe induction stage. Crying and resistance mayincrease this risk even further (7, 28). The findings inour study indicate that dexmedetomidine as paediatricpremedication has favourable effects at the inductionstage of anaesthesia and causes a minimum ofcomplications when the necessary precautions aretaken.

The participants described the perioperative stage ascalm and stable. Previous studies indicate thatdexmedetomidine may reduce the need for anaestheticdrugs perioperatively and prolong the effect of opioids,which may entail a reduced need for analgesicspostoperatively. The studies also indicate thatdexmedetomidine as premedication protects betteragainst postoperative agitation than midazolam (3, 8,29).

The anaesthetic nurses described recoveries that werecharacterised by less crying, agitation and pain. Theparticipants clearly emphasised that the specialistnurses who monitored the children postoperativelypreferred dexmedetomidine over midazolam aspremedication. These findings corroborate studies thatdescribe the sedative and analgesic properties ofdexmedetomidine (1, 8, 21).

Peri- and post-operative experiences

«The anaesthetic nurses described recoveries thatwere characterised by less crying, agitation andpain.»

Page 19: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The half-life of two to three hours explains why thechildren may benefit from the drug at the earlypostoperative stage after short interventions (3, 8, 21).Our findings corroborate that the premedication has abeneficial effect on the entire course of the anaesthesiaprocess (8).

By using a phenomenological-hermeneutic approachwe have gained a deeper understanding of theparticipants’ experiences. These experiences have inturn helped provide an important basis forinterpretation and new knowledge about this topic. Theintra-sample variation in age, gender, departmentculture, professional experience and experience withthe use of dexmedetomidine produced largely identicaldata, which is evidence of a high degree of consistencyin the data material, which in turn is corroborated byrecent research.

We also believe that such intra-sample variation hasreduced the risk of biased elucidations of the researchquestion. In our opinion, the study’s sample andinformational strength are satisfactory in light of theobjective, composition of the sample, theoretical basis,data quality and analysis (30).

None of the authors had any affiliation with thehospitals from which the participants were recruited.This may have helped provide distance and an‘outsider’s’ view of the data. In addition, the firstauthor, who also conducted the interviews, had priorexperience with dexmedetomidine through a pilotproject undertaken at her own workplace involvingchildren who were to undergo an MRI scan whileunder anaesthesia.

Methodological considerations

Page 20: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

The preconceptions that the first author brought withher into the study may have had an effect on ourchoice of research questions, how the interviews andanalyses were conducted and the findings that wepresent. The authors’ long-standing experience of thisresearch field as professional anaesthetic nurses mayhave helped provide unique insights that enabled theidentification of patterns and complexities that wouldhave been less obvious to outsiders (18).

To ensure credibility we included the voices of theparticipants, described the analytical steps and madethe abstraction process transparent. The first and thirdauthors have primarily undertaken the data analysis,first individually and then jointly to achieve consensuson the categories chosen and the design of the topics,and to prevent biased interpretations of the datamaterial (17).

Our findings may be transferable to other departmentswhere anaesthesia personnel are working withchildren, if the department culture and context aretaken into consideration. Data collection methods andanalyses may also be transferable. The findings mustnevertheless be interpreted in light of their basis in theexperiences of a small sample of anaesthetic nurseswith a permanent workplace.

The findings show that the anaesthetic nursesadminister a drug which is well suited aspremedication, provided that the given precautions aretaken. Dexmedetomidine has helped provide bettertreatment options for children and is evidently safe inuse. The sleep-inducing properties of this drug can bemade use of to undertake simple and less painfulprocedures on children. The findings indicate that suchsystematic change processes should be introduced byway of internal pilot projects.

Implications for practice

Implications for further research

Page 21: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

We suggest that further research ought to focus onways in which the potentiating effects ofdexmedetomidine with regard to analgesics andanaesthetic drugs could be exploited in multimodaltreatment and be included in general anaesthesia for anindividually adapted treatment programme.

We also recommend that further research beundertaken on how these sleep-inducing properties canbe exploited to enable various procedures andexaminations. Finding the correct dosage ofdexmedetomidine has proven to be a challenge, and werecommend further research related to age, weight anddosage.

The study provides new knowledge from theanaesthetic nurse’s perspective on the properties andsuitability of dexmedetomidine as paediatricpremedication. The anaesthetic nurses’ experiences aregenerally of a positive nature, and dexmedetomidinehas a beneficial effect on the pre-, peri- and post-operative anaesthesia process in children.

Successful use of dexmedetomidine requires thatspecial and individual precautions be taken at allstages of the anaesthesia process. We neverthelessregard the disadvantages as minor when compared toall the advantages that we have shown.

1. Sun Y, Lu Y, Huang Y, Jiang H. Isdexmedetomidine superior to midazolam as apremedication in children? A meta-analysis ofrandomized controlled trials. Pediatric Anesthesia.2014;24(8):863–74. DOI: 10.1111/pan.12391.

2. Felleskatalogen. Dexdor. Available at:https://www.felleskatalogen.no/medisin/dexdor-orion-573728 (downloaded 24.03.2017).

Conclusion

References

Page 22: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

3. Pasin L, Febres D, Testa V, Frati E, Borghi G,Landoni G, et al. Dexmedetomidine vs midazolam aspreanesthetic medication in children: a meta-analysisof randomized controlled trials. Pediatric Anesthesia.2015;25(5):468–76. DOI: 10.1111/pan.12587.

4. Ghai B, Jain K, Saxema AK, Bhatia N, SodhiKS. Comparison of oral midazolam with intranasaldexmedetomidine premedication for childrenundergoing CT imaging: a randomized, double-blind,and controlled study. Pediatric Anesthesia.2017;27(1):37–44. DOI: 10.1111/pan.13010.

5. Neville DNW, Hayes KR, Ivan Y, McDowellER, Pitetti RD. Double-blind randomized controlledtrial of intranasal dexmedetomidine versus intranasalmidazolam as anxiolysis prior to pediatric lacerationrepair in the emergency department. AcademicEmergency Medicine. 2016;3(8):910–7.

6. Mountain BW, Smithson L, Cramolini M,Wyatt TH, Newmann M. Dexmedetomidine as apediatric anesthetic premedication to reduce anxietyand to deter emergence delirium. AANA Journal.2011;79(3):219–24.

7. Scully SM. Parental presence during pediatricanesthesia induction. AORN Journal. 2007;96(1):26–33. DOI: 10.1016/j.aorn.2011.07.020.

8. Peng K, Wu S, Ji F, Li J. Premedication withdexmedetomidine in pediatric patients: a systematicreview and meta-analysis. Clinics. 2014;69(11):777–86. DOI: 10.6061/clinics/2014(11)12.

9. Wolf AR, Rosenbaum A, Kain ZN, Larsson P,Lönnqvist P-A. The place of premedication inpediatric practice. Pediatric Anesthesia.2009;19(9):817–28. DOI: 10.1111/j.1460-9592.2009.03114.x.

Page 23: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

10. Holm-Knutsen R. Præoperativ vurdering ogforberedelse av barn og forældre. In: Henneberg SW,Hansen TG, eds. Børneanæstesi. 2. ed. Copenhagen:FADLs Forlag; 2015. p. 97–105.

11. Ghali AM, Mahfouz AK, Al-Bahrani M.Preanesthetic medication in children: A comparison ofintranasal dexmedetomidine versus oral midazolam.Saudi J Anaesth. 2011;5(4):387–91. DOI:10.4103/1658-354X.87268.

12. Flynn FM, Sandaker K, Ballangrud R. Aimingfor excellence – A simulation-based study on adaptingand testing an instrument for developing non-technicalskills in Norwegian student nurse anaesthetists. NurseEducation in Practice. 2017;22:37–46.

13. Jeon Y, Lahtinen P, Meretoja R, Leino-Kilpi H.Anaesthesia nursing education in Nordic countries:Literature review. Nurse Education Today.2015;35(5):680–8.

14. Lov 2. juli 1999 nr. 64 om helsepersonell m.v.(helsepersonelloven). Available at:https://lovdata.no/dokument/NL/lov/1999-07-02-64?q ‐helsepersonelloven (downloaded 24.03.2017).

15. Lov 2. juli 1999 nr. 63 om pasient- ogbrukerrettighetsloven (pasientrettighetsloven).Available at:https://lovdata.no/dokument/NL/lov/1999-07-02-63?q ‐pasientrettighetsloven (downloaded 24.03.2017).

16. Nortvedt MW, Jamtvedt G, Graverholt B,Nordheim LV, Reinar LM. Jobb kunnskapsbasert. Enarbeidsbok. 2. ed. Oslo: Akribe; 2014.

17. Polit DF, Beck CT. Nursing research.Generating and assessing evidence for nursingpractice. 9. ed. Philadelphia: Wolters Kluwer,Lippingcott, William & Wilkins; 2012.

Page 24: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

18. Thagaard T. Systematikk og innlevelse. Eninnføring i kvalitativ metode. 4. ed. Bergen:Fagbokforlaget; 2015.

19. Graneheim UH, Lundman B. Qualitativecontent analysis in nursing research: concepts,procedures and measures to achieve trustworthiness.Nurse Education Today. 2004;24(2):105–12. DOI:10.1016/j.nedt.2003.10.001.

20. Sheta SA, Al-Sarheed MA, Abdelhalim AA.Intranasal dexmedetomidine vs midazolam forpremedication in children undergoing complete dentalrehabilitation: a double-blinded randomized controlledtrial. Pediatric Anesthesia. 2014;24(2):181–9. DOI:10.1111/pan.12287.

21. Li A, Yuen VMY, Goulay-Dufay S, KwokPCL. Pharmacokinetics and pharmacodynamics ofdexmedetomidine. Drug Development and IndustrialPharmacy. 2016;42(12):1917–27.

22. Iirola T, Vilo S, Manner T, Aantaa R, LahtinenM, Scheinin KT, et al. Bioavailability ofdexmedetomidine after intranasal administration.European Journal of Clinical Pharmacology.2011;67(8):825–31. DOI: 10.1007/s00228-011-1002-y.

23. Yuen VMY. Dexmedetomidine: perioperativeapplications in children. Pediatric Anesthesia.2010;20(3):256–64. DOI: 10.1111/j.1460-9592.2009.03207.x.

24. Yuen VM, Hui TW, Irwin MG, Yao TJ, WongGL, Yuen MK. Optimal timing for the administrationof intranasal dexmedetomidine for premedication inchildren. Anaesthesia. 2010;65(9):922–9. DOI:10.1111/j.1365-2044.2010.06453.x.

Page 25: Intranasal dexmedetomidine is of benefit as paediatric ... · Objective: To provide new knowledge on the properties of dexmedetomidine and how this drug is suited as premedication

25. Yuen VM, Hui TW, Irwin MG, Yao TJ, ChanL, Wong GL, et al. A randomised comparison of twointranasal dexmedetomidine doses for premedicationin children. Anaesthesia. 2012;67(11):1210–6. DOI:10.1111/j.1365-2044.2012.07309.x.

26. Tug A, Hanci A, Turk HS, Aybey F, Isil CT,Sayin P, et al. Comparison of two different intranasaldoses of dexmedetomidine in children for magneticresonance imaging sedation. Pediatric Drugs.2015;17(6):479–85. DOI: 10.1007/s40272-015-0145-1.

27. Bjørk IT, Solhaug M. Fagutvikling ogforskning i klinisk sykepleie. En ressursbok. 1. ed.Oslo: Akribe; 2015.

28. Berg T, Hagen O. Forebygging og behandlingav anestesirelaterte komplikasjoner. In: Hovind IL, ed.Anestesisykepleie. 2. ed. Oslo: Akribe; 2011. p. 280–306.

29. Yao Y, Qian B, Lin Y, Wu W, Ye H, Chen Y.Intranasal dexmedetomidine reduces minimal alveolarconcentration of sevoflurane for laryngeal maskairway insertion and emergence delirium in children: aprospective, randomized, double-blind, placebo-controlled trial. Pediatric Anesthesia. 2015;25(5):492–8. DOI: 10.1111/pan.12574.

30. Malterud K, Siersma VD, Guassora AD.Sample size in qualitative interview studies: Guided byinformation power. Qualitative Health Research.2016;26(13):1753–60. DOI:10.1177/1049732315617444.